Great post. Thanks.In relation to point 3, I would alter that to break even for this financial year and then cash positive/profit for the 2019/20 financial year.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025